Chronic Condition Management

Apretude is approved for use in at-risk adults and adolescent to reduce the risk of sexually acquired HIV.

Blood clot risk in J&J higher for women, draws CDC concerns

Sanjay Rajagopalan, MD, the Herman K. Hellerstein, MD, chair in cardiovascular research at University Hospitals of Cleveland Harrington Heart & Vascular Institute, discusses the link between cardiovascular disease and air pollution and how primary care doctors can help patients lower their risk of cardiovascular disease caused by air pollution.

Identifying and assisting patients with social determinants is challenging, but can boost outcomes

Women and those in their 50s and early 60s reported the most stress about COVID

PreHevbrio is the only 3-antigen vaccine for Hepatitis B approved for adults

Is more testing the answer to a worsening drug crisis?

The "Cures 2.0" bill, if signed into law, would expand medical research, aid development of new therapies and expand telehealth.

The product is the first interchangeable insulin biosimilar approved by the FDA.

Healthcare staffing shortages exacerbated by the COVID-19 pandemic have intensified an already serious problem in healthcare: clinician burnout.

Until now, measures to prevent cardiovascular diseases have focused almost entirely on individual behavioral and metabolic risk factors.

How medical practices can create effective vaccination programs for the months ahead

As we move beyond COVID-19, The healthcare industry is just beginning to uncover the impact of delayed cancer screenings and care on oncology outcomes.

Proper implementation of remote patient monitoring can be beneficial for practices and patients.

Research shows walking can help middle age adults improve their health and live longer.

Successfully implementing a CCM program starts with laying the operational groundwork.

The number of states with high adult obesity rates is increasing.

Navigating nutrition conversations with patients

I am convinced that primary care and much of medicine today are in an “evidence desert”. Let me explain.

Physicians are recommended to start screening for the disease around age 35.

The approval could provide patients with an additional safe and possibly more cost-effective options to treat diabetes.

Boosting patient adherence can enhance outcomes

Patients in disadvantaged urban areas will have to overcome greater obstacles, with fewer resources.

Drop in overall life expectancy attributed to “mishandling” of the COVID-19 pandemic.

What you need to know about coding a follow-up appointment for Type 2 diabetes.